In response to increasingly stringent regulations for the production of injectable drugs, Ima Life has been pioneering a solution whose technologies hinge on the integrated use of advanced robotics. Both European and North American guidelines, respectively the cGMP Annex 1 and FDA guidelines, are demanding closer attention with regard to eliminating the risk of contamination. The development of Injecta, Ima Life’s fill-finish processing solution for RTU components, which handles injectables in aseptic conditions under isolator, owes a significant part of its ongoing success to the excellent partnership built between Ima Life engineering team and Kawasaki Robotics experts.
Read on